On Fri, 16 Jun 2000 15:03:32 +0200, Bernd Genser
<[EMAIL PROTECTED]> wrote:
> Does anybody know how to calculate the sample size needed to prove
> EQUIVALENCE, not difference of two treatments concerning survival data
> (log-rank test, cox regression).
"Bio-equivalence" might be as close as you will come if you try to
look up keywords. You might find a discussion in Deja News, from a
few months back.
http://www.fda.gov/cder/guidance/1716dft.pdf
- is the Adobe-Acrobat version of a draft document on
"bioequivalence" as it should be used in federal documents such as the
request for approval of a substitute version of a drug.
There are three different ideas discussed. But the simple notion is
that you demonstrate, typically, that all of the 95% Confidence
Interval for drug B is greater than 80% of the point estimate for A
("survival rate"?), and less than 125% of the point estimate for A.
Two one-tailed tests must be performed. The means for A and B must be
pretty close together, and the sampling must be large enough that you
get a pretty narrow CI -- so that all the CI will fall within that
80-125 range.
... "demonstrate practical equivalence" must be more accurate than
saying "prove equivalence."
You will link to an index to a larger list of documents when you
remove the 1716dft.pdf from the URL, above.
--
Rich Ulrich, [EMAIL PROTECTED]
http://www.pitt.edu/~wpilib/index.html
===========================================================================
This list is open to everyone. Occasionally, less thoughtful
people send inappropriate messages. Please DO NOT COMPLAIN TO
THE POSTMASTER about these messages because the postmaster has no
way of controlling them, and excessive complaints will result in
termination of the list.
For information about this list, including information about the
problem of inappropriate messages and information about how to
unsubscribe, please see the web page at
http://jse.stat.ncsu.edu/
===========================================================================